# Erector Spinae Plane Block

> **NCT04118101** · PHASE2,PHASE3 · COMPLETED · sponsor: **Theodor Bilharz Research Institute** · enrollment: 46 (actual)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** ESPB block
- **OTHER:** control

## Key facts

- **NCT ID:** NCT04118101
- **Lead sponsor:** Theodor Bilharz Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-25
- **Primary completion:** 2020-12-10
- **Final completion:** 2021-02-15
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04118101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04118101, "Erector Spinae Plane Block". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04118101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*